# Modification of Epilepsy Screen Questionnaire and Treatment Feasibility Evaluation

> **NCT04939675** · NA · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Zonisamide 100mg
- **DRUG:** Levetiracetam 500mg
- **DRUG:** LamoTRIgine 50mg

## Key facts

- **NCT ID:** NCT04939675
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-01
- **Primary completion:** 2023-06-30
- **Final completion:** 2025-06-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2021-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04939675

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04939675, "Modification of Epilepsy Screen Questionnaire and Treatment Feasibility Evaluation". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04939675. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*